Skip to content

Drug interactions

Bethanechol + Indacaterol-glycopyrronium

Severity: Moderate

Bethanechol and Indacaterol-glycopyrronium: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bethanechol is a muscarinic agonist while glycopyrronium is a muscarinic antagonist, so they have opposing pharmacologic effects. Bethanechol may be less effective, but systemic glycopyrronium exposure from inhalation is low so the effect is usually limited.

What this interaction means in plain words

Bethanechol and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bethanechol belongs to Gastrointestinal Tract; Indacaterol-glycopyrronium belongs to Respiratory.

Evidence level: Low

Why it happens

Pharmacodynamic antagonism at muscarinic receptors.

What to do

Monitor for reduced bethanechol effect, such as persistent urinary retention. Adjust the bethanechol dose if response is inadequate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bethanechol and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bethanechol with Indacaterol-glycopyrronium?

MediHelp rates the interaction as moderate. Bethanechol and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bethanechol is a muscarinic agonist while glycopyrronium is a muscarinic antagonist, so they have opposing pharmacologic effects. Bethanechol may be less effective, but systemic glycopyrronium exposure from inhalation is low so the effect is usually limited.

How serious is the interaction between Bethanechol and Indacaterol-glycopyrronium?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced bethanechol effect, such as persistent urinary retention. Adjust the bethanechol dose if response is inadequate.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in